期刊中文名:眼(yan)部腫瘤學(xue)和病理學(xue)ISSN:2296-4681E-ISSN:2296-4657
該(gai)雜(za)志(zhi)(zhi)國際(ji)簡稱:OCUL ONCOL PATHOL,是(shi)由(you)出版(ban)商Karger出版(ban)的(de)(de)(de)一(yi)本(ben)致(zhi)力(li)于發布--研(yan)究(jiu)新成果的(de)(de)(de)的(de)(de)(de)專(zhuan)業學(xue)(xue)(xue)術(shu)(shu)(shu)期刊(kan)。主(zhu)要(yao)發表刊(kan)登有創見的(de)(de)(de)學(xue)(xue)(xue)術(shu)(shu)(shu)論文(wen)文(wen)章、行(xing)業最新科研(yan)成果,扼要(yao)報道階段性(xing)研(yan)究(jiu)成果和重要(yao)研(yan)究(jiu)工作的(de)(de)(de)最新進展,選(xuan)載對學(xue)(xue)(xue)科發展起指導作用的(de)(de)(de)綜述與專(zhuan)論,促進學(xue)(xue)(xue)術(shu)(shu)(shu)發展,為廣大讀者服務。該(gai)刊(kan)是(shi)一(yi)本(ben)國際(ji)優(you)秀(xiu)雜(za)志(zhi)(zhi),在國際(ji)上有很高的(de)(de)(de)學(xue)(xue)(xue)術(shu)(shu)(shu)影(ying)響力(li)。
《Ocular Oncology And Pathology》是(shi)一本(ben)(ben)以(yi)English為(wei)主的(de)(de)未開放獲取(qu)國際優秀(xiu)期刊(kan),中文名(ming)稱眼部腫瘤(liu)學(xue)和(he)病理(li)學(xue),本(ben)(ben)刊(kan)主要出版、報道領(ling)域(yu)的(de)(de)研(yan)究動(dong)態以(yi)及在該領(ling)域(yu)取(qu)得的(de)(de)各方(fang)面的(de)(de)經驗(yan)和(he)科(ke)研(yan)成果,介紹該領(ling)域(yu)有關(guan)本(ben)(ben)專(zhuan)業的(de)(de)最(zui)新(xin)進展(zhan)(zhan),探討行業發展(zhan)(zhan)的(de)(de)思(si)路(lu)和(he)方(fang)法(fa),以(yi)促(cu)進學(xue)術信息交流,提高(gao)行業發展(zhan)(zhan)。該刊(kan)已被國際權威數據庫SCIE收錄,為(wei)該領(ling)域(yu)相(xiang)關(guan)學(xue)科(ke)的(de)(de)發展(zhan)(zhan)起(qi)到了(le)良好的(de)(de)推動(dong)作用,也得到了(le)本(ben)(ben)專(zhuan)業人員的(de)(de)廣泛(fan)認可。該刊(kan)最(zui)新(xin)影響因(yin)子為(wei)0.9,最(zui)新(xin)CiteScore 指數為(wei)2.4。
Ocular Oncology And Pathology is an academic journal dedicated to the fields of ophthalmic oncology and pathology. This journal publishes research articles on the etiology, development, diagnosis, treatment, and prognosis of tumors in the eyes and surrounding tissues. It provides a professional forum for ophthalmologists, pathologists, oncologists, and other related medical professionals to share the latest research findings and clinical experiences.
This journal covers a wide range of content from basic scientific research to clinical trials, including but not limited to common and rare ophthalmic tumors such as retinoblastoma, uveal melanoma, intraocular lymphoma, etc. The characteristics of the journal lie in its in-depth exploration of the pathophysiology of ophthalmic tumors, as well as the evaluation of new diagnostic tools and treatment methods. In addition, the magazine also focuses on the relationship between tumors and other eye diseases, as well as the development of personalized treatment strategies.
按(an)JIF指標(biao)學科(ke)分區 |
學科:OPHTHALMOLOGY
收錄子集:ESCI
分區:Q4
排名:75 / 95
百分位:
21.6% |
按JCI指標學科分區 |
學科:OPHTHALMOLOGY
收錄子集:ESCI
分區:Q4
排名:73 / 95
百分位:
23.68% |
JCR分區:JCR分區來自科睿唯(wei)安公司,JCR是(shi)一個(ge)(ge)(ge)獨特的(de)多學科期刊(kan)(kan)評價工具,為唯(wei)一提供基于引文數(shu)據(ju)的(de)統(tong)計信息(xi)的(de)期刊(kan)(kan)評價資(zi)源(yuan)。每年發布的(de)JCR分區,設置了254個(ge)(ge)(ge)具體學科。JCR分區根據(ju)每個(ge)(ge)(ge)學科分類按照期刊(kan)(kan)當年的(de)影響因子高低將期刊(kan)(kan)平均(jun)分為4個(ge)(ge)(ge)區,分別為Q1、Q2、Q3和Q4,各占25%。JCR分區中(zhong)期刊(kan)(kan)的(de)數(shu)量是(shi)均(jun)勻分為四個(ge)(ge)(ge)部分的(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Nursing 小類:General Nursing | Q2 | 55 / 139 |
60% |
該(gai)雜(za)(za)(za)志(zhi)是一本國(guo)際優(you)秀(xiu)雜(za)(za)(za)志(zhi),在(zai)國(guo)際上(shang)有(you)較(jiao)高(gao)(gao)的學術影響(xiang)力(li),行業(ye)關(guan)注度(du)很高(gao)(gao),已被國(guo)際權威數據庫SCIE收錄,該(gai)雜(za)(za)(za)志(zhi)在(zai)綜(zong)合(he)專業(ye)領域專業(ye)度(du)認可很高(gao)(gao),對(dui)稿(gao)(gao)件內容的創(chuang)新(xin)性(xing)和學術性(xing)要求很高(gao)(gao),作為(wei)一本國(guo)際優(you)秀(xiu)雜(za)(za)(za)志(zhi),一般投稿(gao)(gao)過審(shen)時間都較(jiao)長,投稿(gao)(gao)過審(shen)時間平均 ,如果想投稿(gao)(gao)該(gai)刊要做好(hao)時間安排。版面費(fei)不祥。該(gai)雜(za)(za)(za)志(zhi)近兩年未被列入預警(jing)名單,建議您(nin)投稿(gao)(gao)。如您(nin)想了(le)解(jie)更多投稿(gao)(gao)政策及(ji)投稿(gao)(gao)方案,請咨(zi)詢(xun)客服(fu)。
若用戶(hu)需要出版服務,請聯系出版商。